Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lexicon Pharmaceutcl (LXRX)

Lexicon Pharmaceutcl (LXRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 713,702
  • Shares Outstanding, K 144,474
  • Annual Sales, $ 24,000 K
  • Annual Income, $ -58,570 K
  • 60-Month Beta 1.46
  • Price/Sales 30.29
  • Price/Cash Flow N/A
  • Price/Book 5.23
Trade LXRX with:

Options Overview Details

View History
  • Implied Volatility 72.36%
  • Historical Volatility 72.38%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 600.42% on 11/05/20
  • IV Low 72.36% on 09/24/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 426
  • Volume Avg (30-Day) 609
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 9,335
  • Open Int (30-Day) 6,997

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.15
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.18
  • Prior Year 0.71
  • Growth Rate Est. (year over year) -121.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.86 +27.98%
on 08/25/21
5.31 -6.97%
on 09/24/21
+0.98 (+24.75%)
since 08/24/21
3-Month
3.26 +51.53%
on 07/27/21
6.06 -18.48%
on 06/25/21
+0.12 (+2.49%)
since 06/24/21
52-Week
1.03 +379.61%
on 11/09/20
9.65 -48.81%
on 02/02/21
+3.49 (+240.69%)
since 09/24/20

Most Recent Stories

More News
Lexicon Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon's president and chief executive officer, will present virtually at the Oppenheimer Fall Healthcare Life Sciences...

LXRX : 4.94 (-1.79%)
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of Care

New guidelines from the European Society of Cardiology recommend addition of SGLT inhibitors to standard of care for patients with acute and chronic heart failure.

LXRX : 4.94 (-1.79%)
Lexicon's Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpoints: Results from Soloist and Scored Trials

Rapid benefit of sotagliflozin supported by data from the SOLOIST and SCORED trials presented at ESC Congress 2021 - The Digital Experience, including:

LXRX : 4.94 (-1.79%)
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates

Lexicon (LXRX) delivered earnings and revenue surprises of 18.75% and 680.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

LXRX : 4.94 (-1.79%)
Lexicon: Q2 Earnings Snapshot

THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Friday reported a loss of $18.1 million in its second quarter.

LXRX : 4.94 (-1.79%)
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that Craig Granowitz, M.D., Ph.D. will join the company as senior vice president and chief medical officer, effective August 2, 2021.

MRK : 73.61 (+0.77%)
LXRX : 4.94 (-1.79%)
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended June 30, 2021 and provided an update on key milestones.

LXRX : 4.94 (-1.79%)
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2021 financial results on Friday, July 30, 2021 before the markets open. Management will conduct a conference call and live...

LXRX : 4.94 (-1.79%)
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be a symposium highlighting sotagliflozin followed by a live video question and answer period during the American Diabetes Association's...

LXRX : 4.94 (-1.79%)
Lexicon Pharmaceuticals to Participate in the 2021 Jefferies Virtual Healthcare Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon's president and chief executive officer, will present at the 2021 Jefferies Virtual Healthcare Conference on Wednesday,...

LXRX : 4.94 (-1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones....

See More

Key Turning Points

3rd Resistance Point 5.58
2nd Resistance Point 5.45
1st Resistance Point 5.19
Last Price 4.94
1st Support Level 4.80
2nd Support Level 4.67
3rd Support Level 4.41

See More

52-Week High 9.65
Fibonacci 61.8% 6.36
Fibonacci 50% 5.34
Last Price 4.94
Fibonacci 38.2% 4.32
52-Week Low 1.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar